sy-008
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 2, 2018 (NCT03462589)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06098612 | Early Phase 1 (Phase 1) | Nov 30, 2023 | Harvard University |
| NCT04345120 | Phase 1 | May 1, 2020 | Yabao Pharmaceutical Group |
| NCT03462589 | Phase 1 | Aug 2, 2018 | Nanjing Medical University, Yabao Pharmaceutical Group |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yabao Pharmaceutical Group | For profit | 2 | 2 | 1 | 2018 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Nanjing Medical University | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1